Seasonal Influenza Vaccines Market

Seasonal Influenza Vaccines Market Sizes by Vaccine Type (Quadrivalent and Trivalent), By Route of Administration (Injections and Nasal Spray), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2024 to 2033

Base Year: 2023 Historical Data: 2020-22
  • Report ID: TBI-14371
  • Published Date: Jun, 2024
  • Pages: 238
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global seasonal influenza vaccines market was valued at USD 7.82 Billion in 2023 and is anticipated to grow at a CAGR of 8.56% from 2024 to 2033. The influenza virus is responsible for seasonal influenza, an acute respiratory viral infection that spreads globally. It manifests with symptoms like fever, coughing, sore throat, aches and pains in the muscles and joints, and chills; additional intestinal effects such as vomiting and diarrhea may also occur. The flu viruses are usually prevalent during wet or winter conditions. The flu vaccine, commonly called the seasonal influenza vaccine, is a preventive strategy to reduce vulnerability against contracting specific strains of influenza viruses during the most common times. Its purpose is to offer immunity against expected versions of these viruses within a particular flu season. Given the constant evolution among different types of influenza viruses, it's crucial to update the vaccine annually to ensure it remains effective against the prevalent strains. This underscores the importance of staying informed and responsible in our healthcare decisions.

Market Introduction:

Every year, the influenza vaccine formulation changes and is established after exhaustive monitoring and analysis of influenza viruses circulating globally. This aspect entails closely monitoring genetic and antigenic properties to pinpoint which strains have a high chance of causing sickness during flu season. After this determination, public health officials will suggest what should be included for optimal protection when creating the upcoming season's vaccines.

Seasonal flu vaccines can either be trivalent, consisting of three strains of the influenza virus, or quadrivalent, with four. These incorporated viruses represent influenza A and B, forms that usually infect humans. Influenza A is classified into subtypes based on its surface proteins, hemagglutinin (H) and neuraminidase (N). The upcoming flu season usually has a vaccine comprising selected strains from both kinds—A and B—expected to spread in circulation during this period. The central objective of the seasonal vaccine is to activate one's immune system in generating safeguarding antibodies against particular strains of influenza virus included within it. This heightened immunological response enables the body to detect and counteract exposure towards these viruses, henceforth minimizing potential illnesses and their respective complications. Although not entirely foolproof nor capable of preventing every case of influenza, administering a flu shot noticeably minimizes severe sicknesses whilst decreasing risks such as pneumonia or other life-threatening scenarios that demand hospitalization.

Seasonal Influenza Vaccines Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • In September 2022: The Scientific Committee on Vaccine Preventable Diseases (SCVPD) under the CHP has advised that the egg-based quadrivalent or recombinant-based quadrivalent influenza vaccines be starred in the northern hemisphere influenza season.

Market Dynamics:


Rising Awareness of Vaccination – The rising awareness of the significance of vaccination in averting influenza epidemics is a major factor propelling growth in the worldwide seasonal influenza vaccine market. As immunization programs are promoted more extensively by governments and healthcare organizations, individuals increasingly acknowledge the advantages of receiving an annual flu shot. Advocacy campaigns, educational activities, and public health initiatives are vital in highlighting just how imperative it is to get vaccinated against influenza each year - as this drives up demand for seasonal flu vaccines on a global scale. This is the primary factor for the market growth and development.


Manufacturing Constraints and Capacity Limitations - Meeting global demand for seasonal influenza vaccines is challenging due to manufacturing constraints and capacity limitations. This complex and resource-intensive process requires specialized infrastructure, expertise, and technology. Challenges, including shortages in raw material supply, production delays, and quality control issues, can hinder vaccine availability in regions with limited manufacturing capabilities or resources. In addition, the need for seasonal retooling of production facilities and regulatory compliance puts further strain on already stretched manufacturing processes, leading to potential bottlenecks that could disrupt vaccine distribution efforts worldwide. This factor is hindering the market growth and development.


Increasing Investments - Investments in seasonal influenza vaccines are increasing worldwide due to the heightened emphasis on pandemic readiness and response. As flu pandemics can threaten public health and global economies, vaccination plays a crucial role in preventing or reducing their impact. Thus, government bodies, healthcare institutions, and vaccine makers have been paying more attention to producing and storing such vaccines as part of wider efforts towards preparedness for pandemics, ultimately fueling market expansion. This factor is anticipated to provide lucrative growth opportunities in the upcoming years.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America region emerged as the most prominent global seasonal influenza vaccines market, with a 41.0% market revenue share in 2023. High healthcare spending, strong vaccination infrastructure, and widespread public health initiatives are among the factors contributing to North America's significant market share in seasonal influenza vaccines. The U.S. leads this trend as its robust immunization programs, government-funded vaccination campaigns, and preventive healthcare measures make it the continent's largest consumer of these vaccinations. This factor is supported by annual recommendations from the CDC mandating flu shots for all individuals aged six months or older, which significantly contributes to high vaccine uptake rates across the country. The rising rates of morbidity and mortality associated with influenza in North America underscore the crucial role that vaccinations play in preventing sickness and minimizing healthcare expenses. During peak flu seasons, outbreaks can burden public health systems considerably, making it necessary to take preemptive measures against this disease. The most effective approach for safeguarding against influenza infection and its related complications is vaccination, a fact that has contributed to an increased demand for seasonal vaccines across North America. The regional market players also engage in various market strategies such as product innovation, product differentiation, mergers, acquisitions, partnerships, and strategic alliances to maintain their competitive edge.

North America Region Seasonal Influenza Vaccines Market Share in 2023 - 41.0%

Check the geographical analysis of this market by requesting a free sample

  • In September 2022: The Department of Health's (DH) Center for Health Protection (CHP) has announced the vaccination program for residential care homes and schools against seasonal influenza. Thus far, around 460 primary schools, 720 kindergartens, kindergarten-cum-child care centers, and child care centers have registered for the immunization program.
Vaccine Type Segment Analysis

The vaccine type segment includes quadrivalent and trivalent. The trivalent segment dominated, with a market share of around 54% in 2023. Trivalent vaccines remain crucial in seasonal influenza vaccination programs, especially in areas with limited resources and vaccine access. They continue to be widely employed across many nations, particularly low—and middle-income nations that face cost restrictions, regulatory approval hurdles, and logistical challenges when making quadrivalent formulations available. Furthermore, trivalent vaccines still serve an important role for specific groups like older people or those who cannot take the quad variant due to health concerns; this demonstrates how trivalent options maintain significance within the global influenza vaccine market. In addition, the global market for seasonal influenza vaccines is affected by various factors such as regulatory requirements, reimbursement policies and market dynamics. Regulatory agencies play a crucial role in dictating vaccine formulation, approval and selection guidelines, which can significantly impact product development strategies adopted by manufacturers entering this competitive space.

Route of Administration Segment Analysis

The route of administration segment includes injections and nasal spray. The injections dominated, with a market share of around 59% in 2023. For decades, the traditional approach to seasonal flu vaccination worldwide has been administering injections through intramuscular or subcutaneous routes. These influenza vaccines can come in different forms, such as trivalent and quadrivalent formulations; healthcare professionals with proper training use syringes and needles for their administration. Such a method presents many benefits, including high vaccine effectiveness, expected immune response, and convenience of storage, which is why it remains the top choice for numerous medical providers and those who receive these vaccinations. Injectable influenza vaccines continue to hold a commanding market share in the global seasonal flu vaccine industry. This aspect can be attributed to their proven track record of safety and effectiveness, regulatory approval and established healthcare infrastructure. Injectable vaccines are prevalent across all age groups, health conditions, and demographics through routine immunization programs or mass vaccination campaigns due to convenience, accessibility, and familiarity among patients and medical experts, contributing significantly towards its widespread acceptance.

Some of the Key Market Players:
  • CSL Seqirus
  • F. Hoffman-La Roche Ltd.
  • AstraZeneca
  • Pfizer
  • Novartis
  • Sanofi
  • Abbott
  • GlaxoSmithKline
  • Merck

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2023 USD 7.82 Billion
Market size value in 2033 USD 17.77 Billion
CAGR (2024 to 2033) 8.56%
Historical data 2020-2022
Base Year 2023
Forecast 2024-2033
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Vaccine Type, Route of Administration

Frequesntly Asked Questions

As per The Brainy Insights, the size of the global seasonal influenza vaccines market was valued at USD 7.82 billion in 2023 to USD 17.77 billion by 2033.

The global seasonal influenza vaccines market is growing at a CAGR of 8.56% during the forecast period 2024-2033.

North America region became the largest market for seasonal influenza vaccines.

The growing awareness of vaccination across the globe is driving the market's growth.

Request Table of Content


This study forecasts revenue at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the global seasonal influenza vaccines market based on below-mentioned segments:

Global Seasonal Influenza Vaccines Market by Route of Administration:

  • Injections
  • Nasal Spray

Global Seasonal Influenza Vaccines Market by Vaccine Type:

  • Quadrivalent
  • Trivalent

Global Seasonal Influenza Vaccines Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa


Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:


Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights


Free Customization


Fortune 500 Clients


Free Yearly Update On Purchase Of Multi/Corporate License


Companies Served Till Date